Delos Capital Archives

1 minute read

TRexBio Closes $84M Series B to Advance Immune-Based Therapeutics

Key Highlights TRexBio raises $84M in Series B led by Delos Capital with new investors Avego BioScience and Agent…

November 15, 2024